Zoledronic acid - PDFSEARCH.IO - Document Search Engine

Zoledronic acid
Results: 198

#	Item
11 $Provider information Bisphosphonate Drug List Selection Proven fracture risk reduction, long-term safety, and an internal analysis of actual fracture rates$	Provider information Bisphosphonate Drug List Selection Proven fracture risk reduction, long-term safety, and an internal analysis of actual fracture rates Add to Reading List Source URL: www.anthem.com Language: English - Date: 2014-12-12 05:23:55 Anatomy Alendronic acid Bisphosphonate Osteoporosis Osteonecrosis of the jaw Zoledronic acid Ibandronic acid Risedronic acid Bone density Bisphosphonates Medicine Health
12	Journal of Clinical Densitometry: Assessment of Skeletal Health, vol. 11, no. 1, 163e187, 2008 Ó Copyright 2008 by The International Society for Clinical Densitometry:163e187/$34.00 DOI: j.jocd.2 Add to Reading List Source URL: www.cyberlogic.org Language: English - Date: 2008-05-22 11:29:27 Radiology Bone density Density Skeletal system Dual-energy X-ray absorptiometry Osteoporosis Hip fracture Osteopenia Zoledronic acid Medicine Bone fractures Health
13 $Pathway from risk factors to pharmacological treatment selection in postmenopausal women Fragility fracture age ≥50 Clinical risk factors aged ≥50$	Pathway from risk factors to pharmacological treatment selection in postmenopausal women Fragility fracture age ≥50 Clinical risk factors aged ≥50 Add to Reading List Source URL: www.sign.ac.uk Language: English - Date: 2015-04-09 04:17:23 Bone fractures Osteopathies Osteoporosis Strontium ranelate Dual-energy X-ray absorptiometry Bisphosphonate Hip fracture Bone density Zoledronic acid Medicine Health Drugs
14 $Pathway from risk factors to pharmacological treatment selection in postmenopausal women Fragility fracture age ≥50 Clinical risk factors aged ≥50$	Pathway from risk factors to pharmacological treatment selection in postmenopausal women Fragility fracture age ≥50 Clinical risk factors aged ≥50 Add to Reading List Source URL: www.sign.ac.uk Language: English - Date: 2015-03-27 04:41:45 Drugs Eli Lilly and Company Osteopathies Osteoporosis Zoledronic acid Strontium ranelate Denosumab Dual-energy X-ray absorptiometry Teriparatide Medicine Bisphosphonates Health
15	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Zoledronic Acid Injection safely and effectively. See full prescribing information for Zoledronic Acid Injection. Zo Add to Reading List Source URL: www.sagentpharma.com Language: English - Date: 2014-11-24 11:09:55 Bisphosphonates Calcium Electrolyte disturbances Imidazoles Zoledronic acid Osteopathies Bisphosphonate Osteoporosis Osteonecrosis of the jaw Medicine Health Chemistry
16	Microsoft Word[removed]Final PSD - BMD for breast cancer pts receiving AI treatment -accessible.DOCX Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2015-04-15 22:13:38 Radiology Osteoporosis Bone density Aromatase inhibitor Denosumab Zoledronic acid Osteopenia Peripheral quantitative computed tomography Tamoxifen Medicine Ribbon symbolism Dual-energy X-ray absorptiometry
17	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Zoledronic Acid Injection safely and effectively. See full prescribing information for Zoledronic Acid Injection. h Add to Reading List Source URL: www.sagentpharma.com Language: English - Date: 2014-11-24 11:14:51 Organic chemistry Organofluorides Imidazoles Zoledronic acid Calcium Electrolyte disturbances Multiple myeloma Pamidronic acid Hypercalcaemia Medicine Bisphosphonates Chemistry
18	Giro_Form_Revised_30Aug_2013 CMYK Add to Reading List Source URL: www.redcross.sg Language: English - Date: 2014-08-15 05:56:37 Bisphosphonates Pharmacology Osteonecrosis of the jaw Aclasta Osteoporosis Zoledronic acid Bisphosphonate European Medicines Agency Avascular necrosis Medicine Health Osteopathies
19	Microsoft Word - acl201014iNZ Add to Reading List Source URL: www.hqsc.govt.nz Language: English - Date: 2015-03-29 22:31:11 Osteopathies Osteoporosis Aclasta Zoledronic acid Hip fracture Hypercalcaemia Osteonecrosis of the jaw Vitamin D Alendronic acid Medicine Health Bisphosphonates
20	MSAC application no 1313 Bone mineral density analyses using Dual Energy X-ray Absorptiometry (DXA) in breast cancer patients receiving aromatase inhibitor treatment June 2014 Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2015-04-09 02:11:13 Dual-energy X-ray absorptiometry Radiology AstraZeneca Osteoporosis Bone density Zoledronic acid Denosumab Alendronic acid Tamoxifen Medicine Bisphosphonates Aromatase inhibitors